Pomalidomide

Pomalidomide is a prescription medication used in combination with other drugs to treat multiple myeloma, a type of cancer that affects the bone marrow. It belongs to a class of drugs called immunomodulatory agents, which work by helping the immune system to fight cancer cells more effectively.
Pomalidomide is typically used when other treatments, such as chemotherapy and immunotherapy, have not been effective or have caused intolerable side effects. It is often administered in combination with other medications, such as dexamethasone, a corticosteroid that helps to reduce inflammation and suppress the immune system.
The exact mechanism of action of pomalidomide is not fully understood, but it is believed to stimulate the production of white blood cells and increase the activity of immune cells, which helps to fight cancer cells more effectively. Additionally, pomalidomide may inhibit the growth of new blood vessels that supply nutrients and oxygen to cancer cells, thus slowing down their growth and spread.
Pomalidomide is available in capsule form and is typically taken once a day, either with or without food. The dosage and duration of treatment depend on the individual’s medical condition, response to therapy, and any potential side effects. It is important to follow the healthcare provider’s instructions carefully and report any adverse reactions promptly.
Pomalidomide has been shown to improve the quality of life and overall survival in patients with multiple myeloma who have not responded well to other treatments. However, it may cause side effects such as anemia, thrombocytopenia, neutropenia, fatigue, constipation, and peripheral neuropathy. Monitor the patient’s blood counts and report any unusual symptoms to the healthcare provider.